The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation
Abstract
BACKGROUND: Mutations in breast cancer susceptibility genes (BRCA1 and BRCA2) are associated with increased risks for breast, ovarian, and other types of cancer. PURPOSE: To review new evidence on the benefits and harms of risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women. DATA SOURCES: MEDLINE and PsycINFO between 2004 and 30 July 2013, the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews from 2004 through the second quarter of 2013, Health Technology Assessment during the fourth quarter of 2012, Scopus, and reference lists. STUDY SELECTION: English-language studies about accuracy of risk assessment and benefits and harms of genetic counseling, genetic testing, and interventions to reduce cancer incidence and mortality. DATA EXTRACTION: Individual investigators extracted data on participants, study design, analysis, follow-up, and results, and a second investigator confirmed key data. Investigators independently dual-rated study quality and applicability by using established criteria. DATA SYNTHESIS: Five referral models accurately estimated individual risk for BRCA mutations. Genetic counseling increased the accuracy of risk perception and decreases the intention for genetic testing among unlikely carriers and cancer-related worry, anxiety, and depression. No trials evaluated the effectiveness of intensive screening or risk-reducing medications in mutation carriers, although false-positive rates, unneeded imaging, and unneeded surgeries were higher with screening. Among high-risk women and mutation carriers, risk-reducing mastectomy decreased breast cancer by 85% to 100% and breast cancer mortality by 81% to 100% compared with women without surgery; risk-reducing salpingo-oophorectomy decreased breast cancer incidence by 37% to 100%, ovarian cancer by 69% to 100%, and all-cause mortality by 55% to 100%. LIMITATION: The analysis included only English-language articles;efficacy trials in mutation carriers were lacking. CONCLUSION: Studies of risk assessment, genetic counseling, genetic testing, and interventions to reduce cancer and mortality indicate potential benefits and harms that vary according to risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Current methods of the U.S. Preventive Services Task Force
Harris, R. P., Helfand, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D., Teutsch, S. M., & Atkins, D. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00261-6 · Cited by 1,731
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., Petty, P. M., Sellers, T. A., Johnson, J. L., McDonnell, S. K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400201 · Cited by 1,423
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Buys, S. S. (2011) · JAMA · doi:10.1001/jama.2011.766 · Cited by 1,323
Systematic Reviews of Diagnostic Test Accuracy
Leeflang, M. M. G., Deeks, J. J., Gatsonis, C., & Bossuyt, P. M. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-12-200812160-00008 · Cited by 1,124
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
Frank, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1480 · Cited by 812
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
Parmigiani, G., Berry, D. A., & Aguilar, O. (1998) · The American Journal of Human Genetics · doi:10.1086/301670 · Cited by 753
Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1633 · Cited by 743
BRCA1 Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer
Couch, F. J., DeShano, M. L., Blackwood, M. A., Calzone, K., Stopfer, J., Campeau, L., Ganguly, A., Rebbeck, T., Weber, B. L., Jablon, L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362002 · Cited by 685
Mavaddat, N., Barrowdale, D., Andrulis, I. L., Domchek, S. M., Eccles, D., Nevanlinna, H., Ramus, S. J., Spurdle, A., Robson, M., Sherman, M., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0775 · Cited by 669
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1480 · Cited by 558
Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ögmundsdottir, H. M., & Eyfjörd, J. E. (1996) · Nature Genetics · doi:10.1038/ng0596-117 · Cited by 525
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
Antoniou, A. C., Cunningham, A. P., Peto, J., Evans, D. G., Lalloo, F., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Southey, M. C., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604305 · Cited by 525
Berry, D. A., Iversen, E. S., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., Lerman, C., Watson, P., Lynch, H. T., Hilsenbeck, S. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.121 · Cited by 505
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1730 · Cited by 484
The BOADICEA model of genetic susceptibility to breast and ovarian cancer
Antoniou, A. C., Pharoah, P. P. D., Smith, P., & Easton, D. F. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602175 · Cited by 467
Armstrong, K. (2005) · JAMA · doi:10.1001/jama.293.14.1729 · Cited by 432
U.S. Preventive Services Task Force* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00011 · Cited by 405
Probability of Carrying a Mutation of Breast-Ovarian Cancer Gene BRCA1 Based on Family History
Berry, D. A., Parmigiani, G., Sanchez, J., Schildkraut, J., & Winer, E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.227 · Cited by 380
Shattuck-Eidens, D. (1997) · JAMA · doi:10.1001/jama.1997.03550150046034 · Cited by 374
Nelson, H. D., Huffman, L. H., Fu, R., & Harris, E. L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00012 · Cited by 346
Self-citationConcise Handbook of Familial Cancer Susceptibility Syndromes - Second Edition
Lindor, N. M., McMaster, M. L., Lindor, C. J., & Greene, M. H. (2008) · JNCI Monographs · doi:10.1093/jncimonographs/lgn001 · Cited by 307
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer
Neuhausen, S., Gilewski, T., Norton, L., Tran, T., McGuire, P., Swensen, J., Hampel, H., Borgen, P., Brown, K., Skolnick, M., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-126 · Cited by 304
Kerber, R. A., & Slattery, M. L. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009259 · Cited by 279
Evans, D. G. R., Eccles, D. M., Rahman, N., Young, K., Bulman, M., Amir, E., Shenton, A., Howell, A., & Lalloo, F. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.017996 · Cited by 265
Brandberg, Y., Sandelin, K., Erikson, S., Jurell, G., Liljegren, A., Lindblom, A., Lindén, A., von Wachenfeldt, A., Wickman, M., & Arver, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9568 · Cited by 265
BRCA1 MUTATIONS IN WOMEN ATTENDING CLINICS THAT EVALUATE THE RISK OF BREAST CANCER
Ouch, F. E. J. C., Hano, M. I. L. D. E. S., Nne, M. A. A., Athleen, K., Topfer, J. I. S., Ampeau, L. I. C., Ebbeck, T. I. R., & Eber, A. L. W. (1997) · Cited by 256
Watson, M., Lloyd, S., Davidson, J., Meyer, L., Eeles, R., Ebbs, S., & Murday, V (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690139 · Cited by 241
Finch, A., Metcalfe, K. A., Chiang, J. K., Elit, L., McLaughlin, J., Springate, C., Demsky, R., Murphy, J., Rosen, B., & Narod, S. A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.12.326 · Cited by 200
Antoniou, A. C., Hardy, R., Walker, L., Evans, D. G., Shenton, A., Eeles, R., Shanley, S., Pichert, G., Izatt, L., Rose, S., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.056556 · Cited by 194
Nelson, H. D., Smith, M. E. B., Griffin, J. C., & Fu, R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-8-201304160-00005 · Cited by 187
Self-citationLerman, C., Schwartz, M. D., Miller, S. M., Daly, M., Sands, C., & Rimer, B. K. (1996) · Health Psychology · doi:10.1037//0278-6133.15.2.75 · Cited by 181
The University of North Carolina at Chapel Hill University Libraries (2020) · PubMed · doi:10.17615/jkkh-v976 · Cited by 167
Founder BRCA1 and BRCA2 Mutations in French Canadian Breast and Ovarian Cancer Families
Tonin, P. N., Mes-Masson, A.-M., Futreal, P. A., Morgan, K., Mahon, M., Foulkes, W. D., Cole, D. E. C., Provencher, D., Ghadirian, P., & Narod, S. A. (1998) · The American Journal of Human Genetics · doi:10.1086/302099 · Cited by 165
Hermsen, B. B. J., Olivier, R. I., Verheijen, R. H. M., van Beurden, M., de Hullu, J. A., Massuger, L. F. A. G., Burger, C. W., Brekelmans, C. T. M., Mourits, M. J. E., de Bock, G. H., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603725 · Cited by 155
Gahm, J., Wickman, M., & Brandberg, Y. (2010) · The Breast · doi:10.1016/j.breast.2010.05.003 · Cited by 146
Lerman, C., Hughes, C., Benkendorf, J., Biesecker, B. B., Kerner, J. F., Willison, J., Eads, N. L., Hadley, D. W., & Lynch, J. W. (1999) · PubMed · Cited by 140
Lobb, E. A., Butow, P. N., Barratt, A. L., Meiser, B., Gaff, C., Young, M., Haan, E., Suthers, G., Gattas, M. R., & Tucker, K. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601502 · Cited by 138
Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy
Metcalfe, K., Esplen, M., Goel, V., & Narod, S. (2004) · Psycho-Oncology · doi:10.1002/pon.726 · Cited by 136
Family history of breast cancer: what do women understand and recall about their genetic risk?
Watson, M., Duvivier, V., Walsh, M. W., Ashley, S., Davidson, J. M., Papaikonomou, M., Murday, V. A., Sacks, N., & Eeles, R. A. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.9.731 · Cited by 135
Kramer, J. L., Velazquez, I. A., Chen, B. E., Rosenberg, P. S., Struewing, J. P., & Greene, M. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9199 · Cited by 135
Psychological impact of genetic testing in women from high-risk breast cancer families
Meiser, B., Butow, P. N., Friedlander, M. L., Barratt, A. L., Schnieden, V., Watson, M., Brown, J. K., & Tucker, K. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00264-2 · Cited by 127
Validity of Models for Predicting BRCA1 and BRCA2 Mutations
Parmigiani, G., Chen, S., Iversen, E. S., Friebel, T. M., Finkelstein, D. M., Anton-Culver, H., Ziogas, A., Weber, B. L., Eisen, A. F., Malone, K. E., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00002 · Cited by 126
A Systematic Review of the Impact of Genetic Counseling on Risk Perception Accuracy
Smerecnik, C. M. R., Mesters, I., Verweij, E., de Vries, N. K., & de Vries, H. (2009) · Journal of Genetic Counseling · doi:10.1007/s10897-008-9210-z · Cited by 125
Prevalence of BRCA1 Mutation Carriers among U.S. Non-Hispanic Whites
Whittemore, A. S., Gong, G. D., John, E. M., McGuire, V. M., Li, F. P., Ostrow, K. L., DiCioccio, R. A., Felberg, A., & West, D. W. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.2078.13.12 · Cited by 124
The use of videotaped information in cancer genetic counselling: a randomized evaluation study
Cull, A., Miller, H., Porterfield, T., Mackay, J., Anderson, E., Steel, C., & Elton, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.135 · Cited by 123
Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population
Bellcross, C. A., Lemke, A. A., Pape, L. S., Tess, A., & Meisner, L. T. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181b9b04a · Cited by 118
Gilpin, C., Carson, N. L., & Hunter, A. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580408.x · Cited by 115
Confirmation of Family Cancer History Reported in a Population-Based Survey
Mai, P. L., Garceau, A. O., Graubard, B. I., Dunn, M. E., McNeel, T. S., Gonsalves, L., Gail, M. H., Greene, M. H., Willis, G., & Wideroff, L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr114 · Cited by 104
Weitzel, J. N., Lagos, V. I., Herzog, J., Judkins, T., Hendrickson, B. C., Ho, J. S., Ricker, C. N., Lowstuter, K. J., Blazer, K. R., Tomlinson, G. E., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0198 · Cited by 100
Assessing BRCA Carrier Probabilities in Extended Families
Barcenas, C. H., Hosain, G. M., Arun, B. K., Zong, J., Zhou, X., Chen, J., Cortada, J. M., Mills, G. B., Tomlinson, G. E., Miller, A. R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2368 · Cited by 100
Le‐Petross, H. T., Whitman, G. J., Atchley, D. P., Yuan, Y., Gutierrez‐Barrera, A. M., Hortobágyi, G. N., Litton, J. K., & Arun, B. (2011) · Cancer · doi:10.1002/cncr.25971 · Cited by 98
Atkins, D. C., Chang, S., Gartlehner, G., Buckley, D., Whitlock, E. P., Berliner, E., & Matchar, D. B. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.11.021 · Cited by 96
van Dijk, S., Timmermans, D. R. M., Meijers-Heijboer, H. E. J., Tibben, A., van Asperen, C. J., & Otten, W. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7259 · Cited by 94
Finch, A., Metcalfe, K. A., Chiang, J., Elit, L., McLaughlin, J. R., Springate, C., Esplen, M. J., Demsky, R., Murphy, J., Rosen, B. P., et al. (2011) · Psycho-Oncology · doi:10.1002/pon.2041 · Cited by 93
Hoskins, K. F., Zwaagstra, A., & Ranz, M. (2006) · Cancer · doi:10.1002/cncr.22202 · Cited by 92
Patients’ Resistance to Risk Information in Genetic Counseling for BRCA1/2
Gurmankin, A. D., Domchek, S. M., Stopfer, J., Fels, C., & Armstrong, K. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.5.523 · Cited by 90
Metcalfe, K. A., Mian, N., Enmore, M., Poll, A., Llacuachaqui, M., Nanda, S., Sun, P., Hughes, K. S., & Narod, S. A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1941-0 · Cited by 88
Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up
Foster, C., Watson, M., Eeles, R., Eccles, D., Ashley, S., Davidson, R., Mackay, J., Morrison, P., Hopwood, P., & Evans, D. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603610 · Cited by 87
Risk reducing mastectomy: outcomes in 10 European centres
Evans, D. G., Baildam, A. D., Anderson, E. D. C., Brain, A., Shenton, A., Vasen, H. F. A., Eccles, D., Lucassen, A., Pichert, G., Hamed, H., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062232 · Cited by 87
Genetic counseling for women with an intermediate family history of breast cancer
Burke, W., Culver, J. O., Bowen, D. J., Lowry, D. K., Durfy, S. J., McTiernan, A., & Andersen, M. R. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000228)90:5<361::aid-ajmg4>3.0.co;2-8 · Cited by 86
Ashton‐Prolla, P., Giacomazzi, J., Schmidt, A. V., Roth, F. L., Palmero, E. I., Kalakun, L., de Aguiar, E. S., Moreira, S. M., Batassini, É., Reyes, V. B., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-283 · Cited by 83
Kriege, M., Brekelmans, C. T. M., Boetes, C., Muller, S. H., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Rutgers, E. J. T., de Koning, H. J., et al. (2006) · Cancer · doi:10.1002/cncr.21863 · Cited by 81
Breast cancer after bilateral risk-reducing mastectomy
Skytte, A., Crüger, D. G., Gerster, M., Lænkholm, A., Lang, C., Brøndum‐Nielsen, K., Andersen, M., Sunde, L., Kølvraa, S., & Gerdes, A. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01604.x · Cited by 76
Impact of screening for breast cancer in high-risk women on health-related quality of life
Rijnsburger, A. J., Essink‐Bot, M., van Dooren, S., Borsboom, G. J. J. M., Seynaeve, C., Bartels, C. C. M., Klijn, J. G. M., Tibben, A., & de Koning, H. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601912 · Cited by 75
Arver, B. W., Haegermark, A., Platten, U., Lindblom, A., & Brandberg, Y. (2004) · Familial Cancer · doi:10.1023/b:fame.0000039863.89137.f9 · Cited by 74
Graves, K. D., Vegella, P. L., Poggi, E. A., Peshkin, B. N., Tong, A., Isaacs, C. J., Finch, C., Kelly, S. P., Taylor, K. L., Luta, G., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0991 · Cited by 74
Reichelt, J. G., Heimdal, K., Møller, P., & Dahl, A. A. (2004) · Familial Cancer · doi:10.1023/b:fame.0000026820.32469.4a · Cited by 73
Selecting a BRCA risk assessment model for use in a familial cancer clinic
Panchal, S., Ennis, M., Cañón, S. C. M., & Bordeleau, L. J. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-116 · Cited by 69
Results of a randomized study of telephone versus in-person breast cancer risk counseling
Helmes, A. W., Culver, J. O., & Bowen, D. J. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2005.12.002 · Cited by 66
Breast cancer risk counseling improves women’s functioning
Bowen, D. J., Burke, W., McTiernan, A., Yasui, Y., & Andersen, M. R. (2003) · Patient Education and Counseling · doi:10.1016/s0738-3991(03)00122-8 · Cited by 64
Matloff, E. T., Moyer, A. E., Shannon, K. M., Niendorf, K. B., & Col, N. F. (2006) · Journal of Women s Health · doi:10.1089/jwh.2006.15.843 · Cited by 60
Psychological Factors Associated with Emotional Responses to Receiving Genetic Risk Information
Bennett, P. D., Wilkinson, C., Turner, J., Brain, K. E., Edwards, R. T., Griffith, G. L., France, B., & Gray, J. R. (2008) · Journal of Genetic Counseling · doi:10.1007/s10897-007-9136-x · Cited by 53
Geirdal, A. Ø., Reichelt, J. G., Dahl, A. A., Heimdal, K., Mæhle, L., Stormorken, A. T., & Møller, P. (2005) · Familial Cancer · doi:10.1007/s10689-004-7995-y · Cited by 48
Benefit Finding in Response to BRCA1/2 Testing
Low, C. A., Bower, J. E., Kwan, L. C., & Seldon, J. L. (2008) · Annals of Behavioral Medicine · doi:10.1007/s12160-007-9004-9 · Cited by 48
Roshanai, A. H., Rosenquist, R., Lampic, C., & Nordin, K. (2009) · Acta Oncologica · doi:10.1080/02841860903104137 · Cited by 47
Julian‐Reynier, C., Mancini, J., Mouret‐Fourme, E., Gauthier‐Villars, M., Bonadona, V., Berthet, P., Fricker, J., Caron, O., Luporsi, É., & Noguès, C. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.241 · Cited by 47
Kinney, A. Y., Bloor, L. E., Mandal, D. M., Simonsen, S. E., Baty, B. J., Holubkov, R., Seggar, K., Neuhausen, S. L., & Smith, K. R. (2005) · Cancer · doi:10.1002/cncr.21479 · Cited by 43
Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance
Spiegel, T. N., Esplen, M. J., Hill, K. A., Wong, J., Causer, P. A., & Warner, E. (2011) · The Breast · doi:10.1016/j.breast.2011.04.004 · Cited by 41
Risk of breast and ovarian cancer in women with strong family histories.
Srivastava, A., McKinnon, W. C., & Wood, M. E. (2001) · PubMed · Cited by 38
Wasteson, E., Sandelin, K., Brandberg, Y., Wickman, M., & Arver, B. W. (2010) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2010.01204.x · Cited by 38
Effects of risk counseling on interest in breast cancer genetic testing for lower risk women
Bowen, D. J., Burke, W., Yasui, Y., McTiernan, A., & McLeran, D. (2002) · Genetics in Medicine · doi:10.1097/00125817-200209000-00007 · Cited by 38
Bilateral oophorectomy and breast cancer risk reduction among women with a family history
Olson, J. E., Sellers, T. A., Iturria, S. J., & Hartmann, L. C. (2004) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2004.03.003 · Cited by 37
Pieterse, A. H., Ausems, M. G. E. M., Spreeuwenberg, P. M. M., & van Dulmen, S. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.01.017 · Cited by 37
Reichelt, J. G., Møller, P., Heimdal, K., & Dahl, A. A. (2008) · Familial Cancer · doi:10.1007/s10689-008-9182-z · Cited by 36
Brandberg, Y., Arver, B. W., Johansson, H., Wickman, M., Sandelin, K., & Liljegren, A. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.10.010 · Cited by 36
Development of a risk assessment tool for women with a family history of breast cancer
Braithwaite, D., Sutton, S. R., Mackay, J., Stein, J., & Emery, J. D. (2005) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2005.06.001 · Cited by 35
Effects of a telephone counseling intervention on sisters of young women with breast cancer
Bloom, J. R., STEWART, S. L., Chang, S. M., & You, M. (2006) · Preventive Medicine · doi:10.1016/j.ypmed.2006.07.002 · Cited by 31
Hopwood, P., Wonderling, D. E., Watson, M., Cull, A., Douglas, F., Cole, T. R. P., Eccles, D., Gray, J., Murday, V. A., Steel, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602081 · Cited by 22
Effects of counseling Ashkenazi Jewish women about breast cancer risk.
Bowen, D. J., Burke, W., Culver, J. O., Press, N. A., & Crystal, S. R. (2006) · Cultural Diversity & Ethnic Minority Psychology · doi:10.1037/1099-9809.11.4.0 · Cited by 21
Geirdal, A. Ø., & Dahl, A. A. (2007) · Psycho-Oncology · doi:10.1002/pon.1198 · Cited by 20
Bennett, P. D., Wilkinson, C., Turner, J., et al. (2008) · Familial Cancer · doi:10.1007/s10689-008-9221-9 · Cited by 20
Kelly, K. M., Senter, L. A., Leventhal, H., Özakinci, G., & Porter, K. M. (2007) · Patient Education and Counseling · doi:10.1016/j.pec.2007.09.007 · Cited by 15
Shochat, T., & Dagan, E. (2010) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2009.00805.x · Cited by 12
Brain, K. E., Parsons, E. P., Bennett, P. D., Cannings-John, R. L., & Hood, K. (2010) · Psycho-Oncology · doi:10.1002/pon.1807 · Cited by 12
Comparative Effectiveness of Medications To Reduce Risk of Primary Breast Cancer in Women
Hd, N., Ren, F., Humphrey, L. L., Meb, S., Jc, G., & Nygren, P. (2009) · Europe PMC (PubMed Central) · Cited by 8
The Roter Interaction Analysis System (RIAS) in oncological consultations: psychometric properties
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1099-1611(1998090)7:5
Cited by
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Botkin, J. R., Belmont, J. W., Berg, J. S., Berkman, B. E., Bombard, Y., Holm, I. A., Levy, H. P., Ormond, K. E., Saal, H. M., Spinner, N. B., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.05.022 · Cited by 898
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Kubik, M., et al. (2019) · JAMA · doi:10.1001/jama.2019.10987 · Cited by 467
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2747 · Cited by 409
Manahan, E. R., Kuerer, H. M., Sebastian, M., Hughes, K. S., Boughey, J. C., Euhus, D. M., Boolbol, S. K., & Taylor, W. A. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07549-8 · Cited by 346
Metadata
- Authors
- Nelson, H. D., Pappas, M., Zakher, B., Mitchell, J. P., Okinaka-Hu, L., & Fu, R.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2014-02-18
- Volume
- 160
- Issue
- 4
- Pages
- 255-266
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2147464456
- Cited by
- 319
- References
- 107
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.